Luca Santarelli, VectivBio CEO
With data from nine-patient study, VectivBio raises $125M ahead of lead program's big readout
VectivBio now has $125 million more to work with.
The Basel, Switzerland-based biotech reported the raise just 20 minutes after it dropped early data from …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
